Mar 21
Successful go-live with ARISE 1.1
ARISg™, Drug safety systems Comments Off on Successful go-live with ARISE 1.1The ARISg post-marketing workflow has been amended with an additional activity to ensure the assignment of a company causality assessment for each Adverse Event pertaining to a solicited report sourced from a non-interventional study or programme. The automated distribution/submission logic has been modified to exclude unrelated Adverse Event reports from being distributed and/or submitted.
VOEGELIN system engineering was providing the project-management for this project at Abbott EPD.